TG Therapeutics Inc Cash Flow Reinvestment Rate
Latest as of June 2026:
0.08x
TG Therapeutics Inc cash flow reinvestment rate. TG Therapeutics Inc (TGTX) has a Cash Flow Reinvestment Rate of 0.08x as of June 2026, reinvesting $1.67 Million (capex $344.00K plus investments $1.32 Million) from operating cash flow of $21.37 Million. Explore debt repayment capacity of TG Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.08x
(Capex + Investments) / Operating CF
Total Reinvested
$1.67 Million
Capex + Investments
Operating Cash Flow
$21.37 Million
USD
Capital Expenditures
$344.00K
USD
TG Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)
TG Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for TG Therapeutics Inc. For the full cash flow conversion analysis, see TGTX operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow